...
Item | Hierarchy | MOVED FROM PROPOSED CHANGES TO PUBLISHED CHANGES | Confirmed Release Date |
---|---|---|---|
1. | Content Improvement | Urinary Bladder Following feedback from translation, descriptions for concepts that contain the word 'bladder' and the site of 89837001|Urinary bladder structure (body structure)| will be updated to include 'urinary' in the FSN and PT, for example: 126885006|Neoplasm of bladder (disorder) will be updated to 126885006|Neoplasm of urinary bladder (disorder). | January 2024 International Release |
2. | Product | International Unit in Descriptions for Clinical Drugs 'International Unit' as a description is arbitrary and to be understood each product requires reference to a particular bioefficacy specification for that entity. Therefore, 'international' is not meaningful or comparable as a description at Clinical Drug level. International unit will be represented as 'unit' in Clinical Drug descriptions and 20 concepts will have their descriptions changed to 'unit' Note: abbreviations will not be used. Editorial Guidance has been drafted. | January 2024 International Release |
3. | Procedure | Inactivation of “RAST” and “RAST test” from subtypes of 104380004 |Allergen specific antibody measurement (procedure)| Based on a proposal by the Allergies and Hypersensitivities CRG, descriptions containing “RAST” and “RAST test” will be inactivated from the concepts in this sub-hierarchy as they are not considered real synonyms. Immunoassays for immunoglobulin specific to an allergen of interest are widely used in the diagnosis of allergic disease. These tests are often incorrectly referred to collectively as "radioallergosorbent tests" ("RAST") because they were the earliest immunoassays to be used extensively. There are a few concepts of type "X mix radioallergosorbent test (procedure)", where RAST is in fact part of FSN. These concepts will be inactivated as they are ambiguous because they do not mention what allergens are being tested for. Replacement concepts, where individual allergens are spelled out, will be created where the information is available. | January 2024 International Release |
4. | Morphologic Abnormality | Inactivation of Congenital Morphologic Abnormality Concepts 37764001 |Congenital abnormal fusion (morphologic abnormality)| and 67798003 |Congenital premature fusion (morphologic abnormality) will be inactivated and replaced by:
These two new concepts do not specify occurrence which is to be modeled separately. As a result of this change the two new concepts can be used to model fetal disorders. This change aligns with the Editorial Guide. | February 2024 International Release |
5. | Clinical Finding | Inactivation of 106109006|Number of previous induced termination of pregnancy (finding)| and Subtypes 106109006|Number of previous induced termination of pregnancy (finding)| and subtypes will be inactivated and replaced by a new concept in the situation with explicit context hierarchy: 1300163008 |Past pregnancy history of multiple induced termination of pregnancy (situation)| This concept is already published. 713649008 |Past pregnancy history of induced termination of pregnancy (situation)| | February 2024 International Release |
6. | Procedure | Update 77465005 |Transplantation (procedure) and Descendants Note this project is ongoing. Proposals for the new model will be considered by the Editorial Advisory Group (EAG). 410820007 |Surgical transplantation - action (qualifier value)| and 129407005 |Grafting - action (qualifier value)| will be siblings (not child-parent relationship) and will be subtypes of 129338005 |Surgical implantation - action (qualifier value)|. 129347002 |Surgical transfer - action (qualifier value)| will no longer be a subtype of 410820007 |Surgical transplantation - action (qualifier value)|. 115956009 |Release (procedure)| will be inactivated and its subtypes remodeled to proximal primitive parent modeling and attributes added where necessary. << 422285003 |Solid organ graft - material (substance)| and its subtypes will be updated from 'graft' to 'transplant'. For example, 420291005 |Transplant heart (substance)| The 77465005 |Transplantation (procedure)subtypes will be remodeled with 410820007 |Surgical transplantation - action (qualifier value) where necessary. Also, certain grafting procedures that were subtypes of transplantation procedure will be remodeled with 129407005 |Grafting - action (qualifier value)|. | February 2024 International Release |
7. | Clinical Finding Morphologic Abnormality Situation with Explicit Context | Remodel 127575007 |Malignant neuroendocrine neoplasm, epithelial (morphologic abnormality)| and Subtypes 127575007 |Malignant neuroendocrine neoplasm, epithelial (morphologic abnormality)|, its subtypes and related disorder concepts will be revised to align with the 5th edition of the WHO Blue Book chapter on Endocrine and Neuroendocrine Tumours as part of the Histology Quality Improvement Project. Please see the briefing note for more information about these changes. | February 2024 International Release |
8. | Procedure | Update for 73632009 |Laparoscopy (procedure)| and Subtypes There will be a bulk update to align 73632009 |Laparoscopy (procedure)| and subtypes with the template here: https://confluence.ihtsdotools.org/display/SCTEMPLATES/Laparoscopy+%28procedure%29+-+Draft These changes include the addition of INCISION ROLE GROUP and INSPECTION ROLE GROUP for all Laparoscopic procedures. | February 2024 International Release |
9. | Clinical Finding | Update for Diabetes Insipidus Based on a report from October 2022 from the Working Group for Renaming Diabetes Insipidus, concepts using the term “Diabetes insipidus” will be renamed and/or replaced with terms that more appropriately represent the pathophysiology of this condition. The top-level concept replacing "Diabetes insipidus" will be "Arginine vasopressin-related polyuria" and the specific subtypes will be represented by two renamed conditions:
The legacy descriptions of "Diabetes insipidus", "Central diabetes insipidus" and "Nephrogenic diabetes insipidus" will be retained where appropriate to facilitate retrieval of concepts by their newer names. This affects approximately 18 existing concepts in SNOMED CT. | February 2024 International Release |
10. | Procedure | 17423001 |Epiphysiodesis (procedure) - Remodel Subtypes Epiphyseal Stapling Epiphyseal stapling concepts will be moved from being a subtype of 17423001 |Epiphysiodesis (procedure)|. Epiphysiodesis is a fusion of the epiphyseal plate resulting in a permanent arrest of growth, whereas Epiphyseal stapling is a fixation of the epiphyseal plate in order to arrest growth and is often reversible once the staples are removed. | February 2024 International Release |
11. | Annotation Reference Set | NOTICE - JUNE 2024 RELEASE - CHANGES TO THE ANNOTATIONS REFSET FORMAT After discussions with the community, SNOMED International has made changes to the coverage of language in the Annotations refsets in the following way:
The addition of content for the Annotations refset will commence in future International Edition releases. | June 2024 International Release |
12. | Morphologic Abnormality | Inactivation of Congenital Morphologic Abnormality Concepts 61295008 |Congenital abnormal number (morphologic abnormality)| 125226006|Congenital malposition, left (morphologic abnormality)| 125225005|Congenital malposition, right (morphologic abnormality)| 56457002|Congenital atresia (morphologic abnormality)| 41086002 |Congenital smallness (morphologic abnormality)| 81850003 |Congenital sequestration (morphologic abnormality)| These concepts will be inactivated and replaced by a concept that does not specify congenital. Concepts that are modeled with these morphologic abnormality concepts will be remodeled using the replacement concept. This change aligns with the Editorial Guide. | March 2024 International Release |
13. | Annotation | OWL Axiom Expressions for Annotation Properties The new annotation properties should be represented in the OWL expression axiom refset as follows:
They should therefore be changed to:
However, the authoring tool will then need to be updated to ensure all new subconcepts of 1295447006 |Annotation attribute (attribute)| will be represented as SubAnnotationPropertyOf() in the future. Numerous other tools will also need to be updated first in order to correctly consume the new format. There are numerous systems that require updating, and that this will therefore need to be carefully tested and rolled out over the next few months. As the potential impact was analysed and deemed to be low, the Annotations deployment will still go ahead as planned in the January 2024 International Edition release, whereas these axiom updates will be published in subsequent releases. Please, therefore, be aware that this issue will persist for the first few International Edition releases of 2024. | Axiom updates published March 2024 International Release Remaining updates to be published in 2024. Please see section above '2024 Proposed Content Changes' for further updates on the remaining content/tooling changes required to complete this item. |
14. | Body Structure | Inactivation of 9258009|Gravid uterus structure (body structure)| This concept will be inactivated, content that is modeled with this concept will be remodeled with a site of 35039007|Uterine structure (body structure)| along with occurrence <<307159006|Pregnancy time period (qualifier value)|. The domain of 246454002 |Occurrence (attribute)| has been extended in the October 2023 release to include << 71388002 |Procedure (procedure)| to support these content changes. Content areas that will be updated include 386811000|Fetal procedure (procedure)| and 386637004|Obstetric procedure (procedure)|. | April 2024 International Release |
15. | Body Structure | Inactivation of Concepts Specified Male/Female in Descriptions 67770001 |Male mammary gland structure (body structure)| and 91532001 |Female mammary gland structure (body structure)| and subtypes plus associated disorder and specimen concepts will be inactivated. Further information is available here (Confluence log in required). NOTE: this update will include the inactivation of neoplasm concepts that specify male/female, this includes <<126927001|Neoplasm of female breast (disorder)| <<126937006|Neoplasm of male breast (disorder)| These concepts will be replaced with a concept that does not specify male/female, a new concept will be added where one does not already exist. | April 2024 International Release |
16. | Procedure | Update Hierarchy 363680008|Radiographic imaging Procedure (procedure)|and Descendants A Briefing Note documenting the proposed changes for the hierarchy 363680008|Radiographic imaging procedure (procedure)| and descendants was shared with the Editorial Advisory Group, Clinical Leads Group, Member Forum, Content Managers Advisory Group, and other key stakeholders in July 2023. Feedback was received from a wide range of stakeholders. In response to this feedback, the proposed changes to the hierarchy have been modified. These modifications will address issues raised in the feedback. This Informational Briefing Note summarizes the changes that will be implemented. Implementation of the content changes will commence in Q4 2023. The updates will be implemented in sub-hierarchies and promoted over a number of international monthly releases until complete. | April 2024 release:
Remaining changes across 2024 International Releases |
17. | Qualifier Value | Change Parent for 410460000|Illumination - action (qualifier value)| and Subtypes 410460000|Illumination - action (qualifier value)| and descendants will be updated to be a subtype of 272394005|Technique (qualifier value)|. The concepts will not be inactivated. Descriptions that currently include '- action’ will be inactivated and replaced. Concepts that are currently modeled with method 410460000|Illumination - action (qualifier value)| will be remodeled with a method of 360037004|Imaging - action (qualifier value)|. These changes will complete this Content Tracker. | April 2024 International Release |
18. | Procedure | Inactivation of 118661008|Physician service (procedure)| and Descendants 118661008|Physician service (procedure)| and subtypes will be inactivated and replaced with concepts that are a subtype of 224891009|Healthcare services (qualifier value)| where appropriate. These changes will complete this Content Tracker. | April 2024 International Release |
19. | Qualifier Value | Addition of New Technique Qualifier Value Concepts Around 80 new laboratory technique concepts will be added in the 272394005 |Technique (qualifier value)| subhierarchy. | March and April 2024 International Releases |
20. | Procedure | Inactivation of 277132007|Therapeutic procedure (procedure) The concept 277132007 |Therapeutic procedure (procedure) will be inactivated with the inactivation reason of Outdated and a replacement association target of 71388002 |Procedure (procedure)|. The nearly 2000 descendants will be reviewed as to the appropriateness of either the Has intent (attribute) of Therapeutic intent, or a Method (attribute) of Therapy - action. For further information please see briefing note. For 1st May 2024 release: The immediate subtypes of <277132007 |Therapeutic procedure (procedure)|, excluding <<416608005 |Drug therapy (procedure)|, will be reviewed for appropriate presence or absence of the Has intent (attribute) according to the Editorial Guide for the 1 May release. A potential concept model for 416608005 |Drug therapy (procedure)| and for 276239002 |Therapy (regime/therapy)| requires further consultation. 277132007 |Therapeutic procedure (procedure)| will remain active until this work has been undertaken please watch the Content Tracker for future development. | May 2024 International Release |
21. | MRCM | Changes to MRCM There are planned changes to MRCM for the attribute in group cardinality to four attributes:
These changes are being made to support the implementation of role group changes to observables and evaluation procedures. The domain "administration via specific route (procedure)" will be removed and the attribute "route of administration" will be optional for the domain of procedure. | May 2024 International Release |
22. | Clinical Finding | Inactivation of 248536006 |Finding of functional performance and activity (finding) This concept will be inactivated: 248536006 |Finding of functional performance and activity (finding). The concept is an intermediate primitive grouper for 2000+ concepts and this inactivation will improve subsumption for content in the hierarchy. | May 2024 International Release |
23. | Procedure | Inactivation of 410770002 |Administration of anesthesia for procedure (procedure)| and Subtypes A Briefing note was presented to Anesthesia CRG with a proposal for review and remodeling of 1263452006 |Anesthesia and/or sedation procedure (procedure)| hierarchy. As part of that proposal, inactivation of 410770002 |Administration of anesthesia for procedure (procedure)| hierarchy was agreed. This inactivation will affect 410770002 |Administration of anesthesia for procedure (procedure)|and subtypes, and 10745231000119102 |Cardiac arrest due to administration of anesthesia for obstetric procedure in pregnancy (disorder)|. Concepts in 410770002 |Administration of anesthesia for procedure (procedure)|hierarchy will be inactivated with Inactivation reason = Outdated component and Replaced by 399097000 |Administration of anesthesia (procedure)|. For 10745231000119102 |Cardiac arrest due to administration of anesthesia for obstetric procedure in pregnancy (disorder)|FSN will be changed to 10745231000119102 |Cardiac arrest due to administration of anesthesia in pregnancy (disorder)| and value for 42752001 |Due to (attribute)| will be changed to 399097000 |Administration of anesthesia (procedure)|. | June 2024 International Release |
24. | Substance | Antibody to X Organism The descriptions for the children of 312301006 |Infective organism antibody (substance)| (antibody to X or X antibody) will be updated as per editorial guidelines where applicable. | June 2024 International Release |
25. | Procedure | Update 71651007|Mammography (procedure)| and Descendants As part of the content update being undertaken for: 363680008|Radiographic imaging Procedure (procedure)| and Descendants (please see item 2 above for details). Content changes will be undertaken for 71651007|Mammography (procedure)| and subtypes. A new concept will be added as the supertype - Imaging of breast (procedure). New imaging actions will be added:
These new actions will distinguish mammography from the less specific action 278110001 |Radiographic imaging - action (qualifier value)|. 71651007|Mammography (procedure)| and subtypes will be modeled with the new imaging action Mammographic imaging - action (qualifier value). NOTE: this change will result in some of the current subtypes of 71651007|Mammography (procedure)| moving up the hierarchy to become subtypes of Imaging of breast (procedure). For example, 709657006|Fluoroscopy of breast (procedure)| will become a subtype of Imaging of breast (procedure) and not 71651007|Mammography (procedure)|. 450566007|Digital tomosynthesis of breast (procedure)| will be sufficiently defined by the new imaging action Mammographic digital tomosynthesis - action (qualifier value) and remain a subtype of 71651007|Mammography (procedure)|. | June 2024 International Release |
26. | Morphologic Abnormality | Update << 1187137001|Squamous intraepithelial neoplasia (morphologic abnormality)| The << 1187137001|Squamous intraepithelial neoplasia (morphologic abnormality)| subhierarchy will be updated to properly represent the two common grading systems used globally. For further information please see this briefing note. | June 2024 International Release |
27. | Social Context | Inactivation of 60134006 |Life style (life style)| and subtypes 60134006 |Life style (life style)| and subtypes will be inactivated as these concept refer to findings about behaviors that an individual has engaged in and not lifestyle. 134436002|Lifestyle (finding)| will also be inactivated. | June 2024 International Release |
28. | Annotation | OWL Axiom Expressions for Annotation Properties The new annotation properties are represented in the OWL expression axiom refset as follows:
These axiom updates are published in the March 2024 International Edition release. The authoring tool has been updated to ensure all new subconcepts of 1295447006 |Annotation attribute (attribute)| are represented as SubAnnotationPropertyOf(). Other tools will be updated to correctly consume the updated syntax. This will be carefully tested and rolled out over the next few months. | June 2024 International Release |
29. | Clinical Finding | Update for Concepts Using 'Caused by' Clinical finding concepts containing "Caused by" in their FSN will be reviewed and will be updated (if applicable) according to the editorial guidelines related to causation here. There is one area where work is still in progress:
| Changes complete July 2024 International Release |
30. | Social Context | Inactivation of Race and Ethnicity Concepts Based on discussions with the Member Forum, all subtypes of 372148003 |Ethnic group (ethnic group)| and most subtypes of 415229000 |Racial group (racial group)| will be inactivated as out of scope for the International release. While all subtypes of 372148003 |Ethnic group (ethnic group)| will be inactivated, the top level concept will be retained for extensions to add their local concepts. All subtypes of 415229000 |Racial group (racial group)| will be inactivated except for the following:
A briefing note is available here. | July 2024 International Release |
31. | Observable Entity/Procedure | Update Role Grouping for Observable Entity and Evaluation Procedure Concepts Currently, Observable Entity concepts’ attributes are self-grouped in the international edition. Based on recommendation by the Modeling Advisory Group (MAG), the policy has changed to group these attributes together in order to support modeling concepts with multiple observations and address inconsistent modeling between evaluation procedures and observable entities. The same changes will be applied to the concepts in the evaluation procedure hierarchy that are modeled with applicable self-grouped attributes. Please see this briefing note for details. Please note that the scope of this change is limited to implementation of the updated role grouping MRCM rules for the observable entity and evaluation procedure hierarchies. There are areas in these subhierarchies that require content improvements , including but not limited to the following areas: complement assays, autoantibody measurements, concepts that refer to more than one Component (examples: ratios and concepts with “And”), Components including “Free” and “Total," concepts with fully defined parents, and procedure concepts modeled with a combination of evaluation procedure attributes and general procedure attributes. Some of the issues were already known and some were identified during this work. These improvements are not in the scope of this work and will be undertaken in future work including the QI project and improvements in other hierarchies including substance and specimen. Some of the issues require feedback from SMEs and/or communication with the Members. If required, editorial guidelines will be updated accordingly. | July 2024 International Release |
32. | Body Structure | Update for Cardiac Wall and Cardiac Segment A proposed new model for this area of content is available here. Further information is available in this briefing note. | July 2024 International Release |
33. | Clinical Finding Procedure Specimen | Update 'Head and Neck' and 'Head and/or Neck' A small number of concepts have been identified with FSN of “head and neck” but modeled with 774007 |Structure of head and/or neck (body structure)|. For some concepts the intention had always been disjunctive “and/or” so to minimise disruption the FSN’s will be changed to reflect this intended meaning with therefore no change in descendants. Procedures such as 430215009 |Biopsy of head and neck structure (procedure)| will be inactivated and replaced with distinct concepts for each body site as a disjunctive in this instance would be a grouper of no clinical significance and non-conformance to editorial policy. This will impact descendants who will become children of the distinct concepts. Examples of concepts to be inactivated and replaced with two distinct concepts:
Examples of concepts with model change to two role groups (finding/disorder can occur in both structures at the same time):
Examples of concepts with FSN change to 'and/or':
| July 2024 International Release |
34. | Procedure | Review of <<75506009 |Construction of stoma (procedure)| A review of the 75506009 |Construction of stoma (procedure)| hierarchy is in progress. The focus is on updating concept modeling, but there will be a small number of inactivations (<20 concepts) and description changes, where appropriate. | July 2024 International Release |
35. | Procedure | Update 42687005|Lymphangiogram (procedure)| and Subtypes 42687005|Lymphangiogram (procedure)| and subtypes have been reviewed as part of the content update being undertaken for: 363680008|Radiographic imaging Procedure (procedure)| and Descendants (please see item 2 above for details). Based on user feedback and review, ‘lymphangiography’ uses fluoroscopy and contrast unless an alternative imaging method such as MRI is specified. The content in this hierarchy that currently states ‘lymphangiography’ or 'lymphangiogram' with method 278110001|Radiographic imaging - action (qualifier value)| will be inactivated and replaced with a new concept which specifies the imaging modality and the use of contrast. For example: 48858003 |Lymphangiography of lower extremity (procedure)| will be inactivated and replaced by a new concept: Fluoroscopic lymphangiography of lower limb with contrast (procedure)| A new supertype concept will be added: 1336147007 |Imaging of lymphatic system (procedure)| | July 2024 International Release |
...